Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis. - Test2 - elhamkhani - TriplyDB

Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

http://www.wikidata.org/entity/Q37433970

about

High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Jap Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells.C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.Smooth muscle cell phenotypic switching in stroke.Metabolic diseases and sex hormone levels affect differently in the development of cardiovascular and cerebrovascular diseases in elderly males.Comparison of insulin resistance in the various stages of chronic kidney disease and inflammation.Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

P2860

Q36239897-E90B165F-932E-4AF9-9ADD-A9EA43FC7AC1 Q36610702-3A1477D4-9F9F-4D60-B1F8-03A6EA039591 Q38112357-6B2919F8-5C73-41EF-B2B8-8AC5F8A82924 Q38170045-7687C27E-F574-4EDC-8901-2F3A6094983B Q44478559-78DDC5CA-DDB3-416B-8313-09FA161B5721 Q51000169-27CD5422-9704-41BA-B145-EE0EDE0DDB12 Q53099325-3E6DF2D1-0BAE-41F9-93A1-26E72568D1E9

P2860

Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

http://www.wikidata.org/entity/Q37433970

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advanced glycation end product ...... asculopathy and atherogenesis.

@en

Advanced glycation end product ...... asculopathy and atherogenesis.

@nl

type

label

Advanced glycation end product ...... asculopathy and atherogenesis.

@en

Advanced glycation end product ...... asculopathy and atherogenesis.

@nl

prefLabel

Advanced glycation end product ...... asculopathy and atherogenesis.

@en

Advanced glycation end product ...... asculopathy and atherogenesis.

@nl

P1433

Q37433970-35F4406B-4D0D-4899-9669-D42532BAA493

P1476

Q37433970-D19DDBC1-7B2C-443B-BFB2-9259A725A97E

P2093

Q37433970-6C7AD896-D0BC-470E-A343-4413C2283241

Q37433970-F0CF1D69-B952-494C-8DDB-79F750F86F22

P2860

Q37433970-4CB6598C-CB47-45A9-AB1A-A1BEB0A3461F

Q37433970-5A854B57-F52D-4405-9492-68D7DEBB010E

Q37433970-67E682C2-DC65-4F71-A50A-34074DE201C4

Q37433970-8E8BF2B1-1962-45A6-813D-3B0CA51FDA24

Q37433970-93E5022C-6908-49AC-988A-F19F14A71F71

Q37433970-CF5BDE54-23BC-4D50-9E70-45944C64AB89

Q37433970-FB19DA7F-D7D5-4A51-9CAD-77B717569EE1

P2888

Q37433970-B7181C39-08DA-4C4D-BC98-75F6227E2183

P304

Q37433970-97994AF5-2376-4F26-82B9-81A550DAD78D

P31

Q37433970-778AA02A-30B3-4924-B184-A9FBD310C7FD

P356

Q37433970-876CF894-38CB-485B-86E9-DF698D0B94E8

P433

Q37433970-57CF5EEB-A750-4836-A687-745B91B9FDFD

P478

Q37433970-B52D69CE-646D-49A4-8169-048AA5BFA697

P577

Q37433970-C20E31E0-A955-49DD-BAE2-28C657134443

P698

Q37433970-54F4D2BA-2F0B-4E09-A9BE-8CAF799B5EF0

P356

S00281-009-0144-9

P1433

Seminars in Immunopathology

P1476

Advanced glycation end product ...... asculopathy and atherogenesis.

@en

P2093

Daniel Walcher

http://www.w3.org/2001/XMLSchema#string

Nikolaus Marx

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?

P2888

s00281-009-0144-9

P304

103-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00281-009-0144-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19347338

http://www.w3.org/2001/XMLSchema#string